TIMP2 and breast carcinoma: Indeed, a negative outcome of certain malignancies correlates more closely with TIMP-2 levels than with MT1-MMP levels [28–35], and high TIMP-2 levels in primary breast carcinomas are associated with the development of distant metastases [30,36].